SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray ($TLRY) is trending due to reports that Trump is considering reclassifying marijuana, potentially easing federal restrictions. The news has sparked discussions around a possible sector-wide short squeeze, with the community debating potential price targets and optimal trading strategies. Some traders are cautioning against FOMO, while others are highlighting the stock's volatile history and reverse split.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending due to a mixed reaction to its earnings report; despite beating expectations and providing strong AI revenue guidance, the stock dipped as investors focused on margin concerns and a lack of specific long-term outlook. The community is debating whether this pullback is a buying opportunity or a sign of broader AI sector concerns, with many analysts reiterating bullish price targets amid the selloff.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors discuss Needham's price target increase alongside the company's autonomy and AI day. Community members are focused on the potential for a short squeeze and Rivian's advancements in AI and self-driving technology, especially relative to competitors like Tesla. Some are expressing concerns about the timeline for new technology and potential delays.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending following a positive earnings report and the announcement of a CEO succession plan. Community discussion revolves around the implications of the leadership change and the impact of the $1 billion buyback program. Despite margin concerns, global growth is driving bullish sentiment for the athleisure brand.

Katapult Holdings, Inc. is an e-commerce focused financial technology company. The firm is engaged in the provision of e-commerce point-of-sale lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.

Katapult Holdings Inc

Katapult (KPLT) is trending due to news of a potential all-stock deal, sparking discussions around the deal's value and potential dilution for current shareholders. The community is focused on the implications of the merger, possible price targets, and whether to hold or sell their shares. Trading halts and high volatility are also contributing to the heightened interest in KPLT.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst ($BCRX) is trending as traders discuss the potential impact of the upcoming FDA decision on Orladeyo for pediatric patients, with some anticipating a revenue boost while others believe it's already priced in. Community members are actively debating the stock's valuation, short interest, and the potential for a buyback program to drive the price higher. The acquisition of Astria Therapeutics and the departure of a board member are also being considered as factors influencing the stock's future performance.

Jiuzi Holdings, Inc. engages in franchise and operation of retail stores. The firm sells new energy vehicles (NEVs) under the brand name Jiuzi. It operates through the NEVs Sales and Franchise Services segments. The company was founded on October 10, 2019 and is headquartered in Hangzhou, China.

Jiuzi Holdings Inc

JZXN is trending following news of a partnership related to a significant $1 billion Bitcoin treasury plan, leading to discussions about potential institutional yields. The community is actively speculating on whether JZXN can replicate the success of other low-float stocks and achieve a substantial price surge. Some traders express skepticism, citing the history of Chinese stocks, while others remain optimistic, anticipating a potential short squeeze.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF ($MSOS) is trending amidst speculation that President Trump is considering reclassifying marijuana as a Schedule III drug, potentially easing federal restrictions and benefiting cannabis companies. Community discussions revolve around the potential impact on specific MSOs, particularly those with significant operations in states poised for adult-use legalization, and the possibility of a short squeeze. Some investors express skepticism, citing past false starts, while others anticipate a significant surge if reclassification occurs.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

FRMI is trending due to a significant drop following the termination of an agreement with its first tenant, sparking concerns about the company's data center project and future prospects; however, some investors believe the market overreacted, citing the long-term potential of AI-driven infrastructure and the company's ongoing negotiations for new tenants, while others are calling the company a scam. Community members are actively discussing potential entry points, short borrow availability, and speculating on the identity of the tenant that cancelled the agreement.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors focus on its potential in cancer treatment, specifically highlighting recent data in prostate cancer trials and a potentially undervalued stock. The community is buzzing about a possible short squeeze due to the high short interest. Buyout or partnership speculation is also contributing to the heightened interest and driving the stock's momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BWVI  - Any of the crew in here know what&#39;s up with BWVI&#39;s old partner $EXPL? I see the stock is up 500% ... I was left holding a big bag of sunken treasure after the end of september

StockTwits Web

Blue Water Ventures International Inc

Endurance Exploration Group, Inc.

  - Any of the crew in here know what's up with BWVI's old partner 

? I see the stock is up 500% ... I was left holding a big bag of sunken treasure after the end of september

Tony T

Andrew Scott

@apscott212 - Thanks. I saw that, its just that the stock is dark/defunct..so it made me wonder why anyone would be buying.. I am sitting on a bunch that would be nice to unload

 - Thanks. I saw that, its just that the stock is dark/defunct..so it made me wonder why anyone would be buying.. I am sitting on a bunch that would be nice to unload